Top

Published in:

06-11-2021 | Original Article

Vaginal pessary in advanced pelvic organ prolapse: impact on quality of life

Authors: Barbara Bevilacqua Zeiger, Silvia da Silva Carramão, Carlos Antônio Del Roy, Thais Travassos da Silva, Susane Mei Hwang, Antonio Pedro Flores Auge

Published in: International Urogynecology Journal | Issue 7/2022

Abstract

Introduction and hypothesis

Pelvic organ prolapse (POP) is a highly prevalent dysfunction of the pelvic floor affecting up to 40% of women. The symptoms of POP have a major impact on quality of life. Pessary treatment is a therapy option associated with high levels of satisfaction and few complications.

Objectives

The objective was to assess the impact and efficacy of vaginal pessary use on the quality of life of women with advanced POP stages III and IV.

Materials and methods

A multicenter, longitudinal, prospective observational study was conducted at the Urogynecology Sector of the Hospital Ipiranga and the Hospital Central of the Irmandade da Santa Casa de Misericórdia de São Paulo. A sociodemographic questionnaire was employed and two scales validated in Portuguese (ICIQVS and SF 12) were applied before and 6 months after pessary use. Student´s t test, Mann–Whitney test and Fisher´s exact test were applied, adopting a significance level of 0.05.

Results

The median age of participants was 71.5 (65–76) years and the median number of pregnancies was 4 (3–5). Deliveries were predominantly vaginal (82.5%). Women sexually active (16.49%) showed improvement in sexual function (78.6%). The participants showed improvement in vaginal symptoms (91.8%) and quality of life (92.8%) (p < 0.01) post-treatment. Of the total 97 women, the sample drop-out rate was 9.3% and 88 participants completed the two stages of the study.

Conclusions

Vaginal pessary use had 90.7% efficacy, a high level of treatment satisfaction (75.3%), and a positive impact on the improvement of vaginal and sexual symptoms, quality of life, and mental health.

Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol. 2006;194(5):1455–61. https://doi.org/10.1016/j.ajog.2006.01.060.CrossRefPubMed

Subak LL, Waetjen LE, van den Eeden S, Thom DH, Vittinghoff E, Brown JS. Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol. 2001;98(4):646–51. https://doi.org/10.1016/s0029-7844(01)01472-7.CrossRefPubMed

Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ prolapse in the United States, 1979–1997. Am J Obstet Gynecol. 2003;188(1):108–15. https://doi.org/10.1067/mob.2003.101.CrossRefPubMed

DeLancey JOL. The hidden epidemic of pelvic floor dysfunction: achievable goals for improved prevention and treatment. Am J Obstet Gynecol. 2005;192(5):1488–95. https://doi.org/10.1016/j.ajog.2005.02.028.CrossRefPubMed

DATASUS. Demográficas e socioeconômicas. http://datasus.saude.gov.br/informacoes-de-saude/tabnet/demograficas-e-socioeconomicas. 2000.

Silva Filho AL, Fonseca AMRM, Camilatto ES, Cangussu RO. Análise dos recursos para reabilitação da musculatura do assoalho pélvico em mulheres com prolapso e incontinência urinária. Fisioter Pes. 2013;20(1):90–6. https://doi.org/10.1590/S1809-29502013000100015.CrossRef

Instituto Brasileiro de Geografia e Estatística (IBGE), Fundo de População das Nações Unidas (UNFPA). Indicadores sociodemográficos prospectivos para o Brasil 1991–2030. 2006. http://www.unfpa.org.br/Arquivos/PDS_Sociodemographic_indicators.pdfgov.br/home/estatistica/populacao/projecao_da_populacao/ publicacao_UNFPA.pdf. Acessed 5 Feb 2008.

Petros P. The integral system. Cent European J Urol. 2011;64(3):110–9.CrossRef

Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27(2):165–94.CrossRef

10.

Büyükbayrak EE, Yilmazer G, Özyapi AG, Kars B, Karsidag AYK, Turan C. Successful management of uterine prolapse during pregnancy with vaginal pessary: a case report. J Turk Ger Gynecol Assoc. 2010;11(2):105–6.CrossRef

11.

Lamers BHC, Broekman BMW, Milani AL. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J. 2011;22(6):637–44. https://doi.org/10.1007/s00192-011-1390-7.CrossRefPubMedPubMedCentral

12.

Teixeira AS. Faculdade de educação e meio ambiente, pp 1–45. 2011.

13.

Coelho SCA, Giraldo PC, Florentino JO, de Castro ED, Brito LGO, Juliato CRT. O uso de pessário vaginal pode alterar a flora microbiológica? Um estudo transversal. Rev Bras Ginecol Obstet. 2017;39(4):169–74.CrossRef

14.

McIntosh L. The role of the nurse in the use of vaginal pessaries to treat pelvic organ prolapse and/or urinary incontinence: a literature review. Urol Nurs. 2005;25(1):41–8.PubMed

15.

Patel M, Mellen C, O’Sullivan DM, LaSala CA. Impact of pessary use on prolapse symptoms, quality of life, and body image. Am J Obstet Gynecol. 2010;202(5):499.e1–.e4. https://doi.org/10.1016/j.ajog.2010.01.019

16.

Coelho SCA, de Castro EB, Juliato CRT. Female pelvic organ prolapse using pessaries: systematic review. Int Urogynecol J. 2016;27(2):1797–803. https://doi.org/10.1007/s00192-016-2991-y.CrossRef

17.

Mao M, Ai F, Kang J, Zhang Y, Liang S, Zhou Y, Zhu L. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse. Menopause. 2009;26(2):145–51. https://doi.org/10.1097/GME.0000000000001197.CrossRef

18.

Silva CHM. Manual SOGIMIG de Uroginecologia. 1st ed. Rio de Janeiro: Med Book; 2019. p. 145–55.

19.

Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic organ dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.CrossRef

20.

Tamanini JTN, Almeida FG, Girotti ME, Riccetto CLZ, Palma PCR, Rios LAS, et al. The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ prolapse. Int Urogynecol J. 2008;19(10):1385–91. https://doi.org/10.1007/s00192-008-0641-8.CrossRef

21.

Silveira MF, Almeida JC, Freire RS, Haikal DS, Martins AEBL. Psychometric properties of the quality of life assessment instrument: 12-item health survey (SF-12). Ciên Saúde Colet. 2013;18(7):1923–31. https://doi.org/10.1590/s1413-81232013000700007.CrossRefPubMed

22.

Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(4):1025–9. https://doi.org/10.1016/j.ajog.2003.10.711.CrossRefPubMed

23.

Fernando RJ, Thakar R, Sultan AH, Shah SM, Jones PW. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstet Gynecol. 2006;108(1):93–9. https://doi.org/10.1097/01.AOG.0000222903.38684.cc.CrossRefPubMed

24.

Maito JM, Quam ZA, Craig E, Danner KA, Rogers RG. Predictors of successful pessary fitting and continued use in a nurse-midwifery pessary clinic. J Midwifery Womens Health. 2006;51(2):78–84. https://doi.org/10.1016/j.jmwh.2005.09.003.CrossRefPubMed

25.

Barros CR, Machado RBB, Camargo ACM, Gollop TR. Tratamento conservador de prolapso de órgão pélvico com pessário: revisão de literatura. Rev Med. 2018;97(2):154–9. https://doi.org/10.11606/issn.1679-9836.v97i2p154-159.CrossRef

Title: Vaginal pessary in advanced pelvic organ prolapse: impact on quality of life
Authors: Barbara Bevilacqua Zeiger
Silvia da Silva Carramão
Carlos Antônio Del Roy
Thais Travassos da Silva
Susane Mei Hwang
Antonio Pedro Flores Auge
Publication date: 06-11-2021
Publisher: Springer International Publishing
Published in: International Urogynecology Journal / Issue 7/2022
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-021-05002-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Vaginal pessary in advanced pelvic organ prolapse: impact on quality of life

Abstract

Introduction and hypothesis

Objectives

Materials and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction and hypothesis

Objectives

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2022

A commentary on “Pessary fitting for pelvic organ prolapse: parameters associated with specific reasons for failure”

Voiding function after sacrocolpopexy versus native tissue transvaginal repair for apical pelvic organ prolapse in an ERAS era: A retrospective cohort study

Stress urinary incontinence and the forgotten female hormones

Laparoscopic synthetic mesh explantation after sacrohysteropexy

Risk factors for recurrence of pelvic organ prolapse after vaginal surgery among Ugandan women: a prospective cohort study

Letter to the editor: absorbable versus non-absorbable sutures for vaginal mesh attachment during sacrocolpopexy: a randomized controlled trial